Meds A-Z
Dexamethasone
Detailed information about Dexamethasone
Official label facts
Owner quick guide first
Marketing clearly labeled
Veterinary professional?
Showing simplified owner view. Switch to Vet View for full technical detail.
Add to My Pet's Meds
Choose a pet, confirm current or past, and optionally add reminder notes.
Sign in to save this medication to your pet profile.
Sign in to continueReviewed / Updated / Sources
Reviewed: Not available
Updated: February 12, 2026, 10:44 PM UTC
Sources:
- FDA application profile · official_label
- FDA application profile · official_label
- Medication usage source · fda_animal_drugs
- Dexamethasone Solution · official_label
- openFDA case USA-USFDACVM-2025-US-053366 · adverse_reaction
Pet Owner Quick Guide
Start here first for the simple next-step summary.
Used for:
For the treatment of otitis externa associated with susceptible strains of yeast ( Malassezia pachydermatis ) and bacteria ( Staphylococcus pseudintermedius ) in dogs.
What to watch for:
- Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy
- and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis
- Do not use in viral infections
- Anti-inflammatory action of corticosteroids may mask signs of infections
- Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy
- Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis
- Not for use in horses intended for food
- very low energy (1 reports)
- Loss of appetite (1 reports)
- Localised pain NOS (1 reports)
When to call the vet:
- Repeated vomiting or diarrhea.
- Severe lethargy (hard to wake, very low energy).
- Collapse or fainting.
- Trouble breathing.
- Facial swelling or hives.
- Blood in vomit or stool.
Regulatory restrictions are shown in Vet View.
What to ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Safety & side effects
What to watch:
- Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy
- and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis
- Do not use in viral infections
- Anti-inflammatory action of corticosteroids may mask signs of infections
- Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy
Most reported reactions:
- Tiredness (lethargy) (1 reports)
- Loss of appetite (1 reports)
- Localised pain NOS (1 reports)
When to call your vet:
- Repeated vomiting or diarrhea.
- Severe lethargy (hard to wake, very low energy).
- Collapse or fainting.
- Trouble breathing.
Data freshness: source data appears current.
Latest refresh: Mar 21, 2026, 10:01 a.m.
Data freshness
- Medication catalog: Source Roxee | Refreshed Feb 12, 2026, 10:44 PM UTC
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Mar 21, 2026, 10:01 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Mar 21, 2026, 10:01 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Mar 16, 2026, 10:04 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:20 AM UTC
Image coming soon
Dexamethasone
Dexamethasone
Drug type: Generic ingredient • Branded profile • FDA branded products available
Species: Both
Manufacturer: Intervet, Inc.
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
Species: Both
Manufacturer: Intervet, Inc.
Form: Bolus, Injectable Solution, Liquid, Liquid (Solution), Liquid (Suspension), Otic Suspension
Identifiers:
ANADA: 200108
ANADA: 200312
ANADA: 200317
ANADA: 200324
ANADA: 200456
ANADA: 200565
NADA: 104606
NADA: 108687
NADA: 110046
NADA: 110349
NADA: 110350
NADA: 111369
NADA: 11885
NADA: 11901
NADA: 123815
NADA: 12559
NADA: 128089
NADA: 130660
NADA: 141598
NADA: 30136
Source metadata:
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/141598 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200317 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source
Warnings / Contraindications
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy; and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infections. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food.
- High: Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy; and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infections. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food.
Source metadata:
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Tap or hover a reaction to see what it means in plain language.
Tracked signals
32
Reported cases
32
Serious reports
28
Species represented
2
Grouped by Body System
Digestive (3)
· Loss of appetite, Diarrhea, Decreased appetite
Neurologic (2)
· Unsteady walking (ataxia), Tiredness (lethargy)
Effectiveness (1)
· Lack of efficacy - NOS
Other (26)
· Localised pain NOS, Leucocytosis NOS, Lameness
Most Reported Reactions
| Reaction | Body system | Cases | Species | Serious cases |
|---|---|---|---|---|
| Neurologic | 1 | Dog | 1 | |
| Digestive | 1 | Dog | 1 | |
| Other | 1 | Dog | 1 | |
| Other | 1 | Dog | 1 | |
| Other | 1 | Dog | 1 | |
| Effectiveness | 1 | Dog | 1 | |
| Other | 1 | Cat | 1 | |
| Other | 1 | Dog | 1 |
Species coverage: Dog (24) Cat (8)
View detailed reaction table
| Reaction | Body system | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|---|
| Neurologic | Cat | Non-serious | - | 1 | |
| Neurologic | Dog | Serious | - | 1 | |
| Digestive | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Effectiveness | Dog | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Non-serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Digestive | Dog | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Digestive | Cat | Non-serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Cat | Non-serious | - | 1 | |
| Other | Dog | Serious | - | 1 |
Source metadata:
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2025-US-053366
Documents
Owner handouts and official technical documents are grouped for faster access.
Owner handouts (0)
- No owner handouts linked yet.
Official label / PI (0)
- No official label or package insert links yet.
SPL (30)
-
Otiserene®
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/17106/Otiserene%C2%AE
-
Dexium-SP™
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/156/Dexium-SP%E2%84%A2
-
Dexamethasone Solution
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2572/Dexamethasone%20Solution
-
Voren® Suspension
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1095/Voren%C2%AE%20Suspension
-
Zonometh Solution
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/512/Zonometh%20Solution
-
Dexameth-A-Vet
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1924/Dexameth-A-Vet
-
Dexameth-A-Vet Injection
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1919/Dexameth-A-Vet%20Injection
-
Dex-A-Vet Injection
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1910/Dex-A-Vet%20Injection
-
Dex-A-Vet Injection
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1918/Dex-A-Vet%20Injection
-
Dexium®
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/132/Dexium%C2%AE
-
Dexium™ Tablets
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1300/Dexium%E2%84%A2%20Tablets
-
Dexamethasone Injection
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1917/Dexamethasone%20Injection
-
Dexamethasone Solution
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/46/Dexamethasone%20Solution
-
Dexamethasone Sterile Solution
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2005/Dexamethasone%20Sterile%20Solution
-
Pet Derm® III Tablets
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1499/Pet%20Derm%C2%AE%20III%20Tablets
-
Azium® Aqueous Suspension Veterinary
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/700/Azium%C2%AE%20Aqueous%20Suspension%20Veterinary
-
Azium® Boluses 10 mg
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1150/Azium%C2%AE%20Boluses%2010%20mg
-
Azium® Oral Solution 2 mg
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1299/Azium%C2%AE%20Oral%20Solution%202%20mg
-
Azium® Powder
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1149/Azium%C2%AE%20Powder
-
Azium® Solution
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/721/Azium%C2%AE%20Solution
-
Azium® Tablets 0.25 mg
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/698/Azium%C2%AE%20Tablets%200.25%20mg
-
Dexachel
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2164/Dexachel
-
Dexamethasone Injection
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1747/Dexamethasone%20Injection
-
Dexamethasone Injection
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1748/Dexamethasone%20Injection
-
Dexamethasone Injection
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/92/Dexamethasone%20Injection
-
Dexamethasone Sodium Phosphate Inj.
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1727/Dexamethasone%20Sodium%20Phosphate%20Inj.
-
Dexamethasone Sodium Phosphate Inj.
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1976/Dexamethasone%20Sodium%20Phosphate%20Inj.
-
Naquasone® Bolus
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1721/Naquasone%C2%AE%20Bolus
-
Thiabendazole, Dexamethasone, Neomycin Sulfate Solution
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2271/Thiabendazole%2C%20Dexamethasone%2C%20Neomycin%20Sulfate%20Solution
-
Tresaderm Dermatologic Solution
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/794/Tresaderm%20Dermatologic%20Solution
FOI (7)
-
FOI Summary oN 141-598 Approved April 10 2025_ceg_ef.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/16805
-
ucm061771.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1065
-
UCM492475.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1176
-
ucm061765.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1060
-
A200108_Org_4_13_1995.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1344
-
ucm061789.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1075
-
UCM457231.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1245
Source metadata:
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/16805 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/17106/Otiserene%C2%AE · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1065 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/156/Dexium-SP%E2%84%A2 · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1176 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2572/Dexamethasone%20Solution · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1095/Voren%C2%AE%20Suspension · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/512/Zonometh%20Solution · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1924/Dexameth-A-Vet · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1919/Dexameth-A-Vet%20Injection · document · SPL
Veterinary reference (advanced)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
Data freshness
- Medication catalog: Source Roxee | Refreshed Feb 12, 2026, 10:44 PM UTC
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Mar 21, 2026, 10:01 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Mar 21, 2026, 10:01 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Mar 16, 2026, 10:04 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:20 AM UTC
Official (FDA)
Identity: Generic ingredient
• FDA branded products available
Official FDA brands:
Azium® Aqueous Suspension Veterinary
Azium® Boluses 10 mg
Azium® Oral Solution 2 mg
Azium® Powder
Azium® Solution
Azium® Tablets 0.25 mg
Dex-A-Vet Injection
Dexachel
Dexameth-A-Vet
Dexameth-A-Vet Injection
Dexamethasone Injection
Dexamethasone Sodium Phosphate Inj.
Dexamethasone Solution
Dexamethasone Sterile Solution
Dexium-SP™
Dexium®
Dexium™ Tablets
Naquasone® Bolus
Otiserene®
Pet Derm® III Tablets
Thiabendazole, Dexamethasone, Neomycin Sulfate Solution
Tresaderm Dermatologic Solution
Voren® Suspension
Zonometh Solution
Case-reported brands (openFDA):
MSK
Catalog species: Both
•
FDA-labeled species: Cat, Dog, Horse, No Use Class Stated Or Implied
Rx/OTC: RX
Form/route:
Bolus, Injectable Solution, Liquid, Liquid (Solution), Liquid (Suspension), Otic Suspension, Powder, Solution, Tablet, Tablet (Chewable)
• Intramuscular, Intravenous, Oral, Otic, Topical
Applications: NADA 141-598 • ANADA 200-317 • ANADA 200-456 • NADA 93600 • NADA 128-089 • NADA 99607 • NADA 99606 • NADA 99604 • NADA 99605 • ANADA 200-312 • NADA 95218 • NADA 104-606 • ANADA 200-108 • NADA 111-369 • NADA 108-687 • NADA 11901 • NADA 30435 • NADA 92835 • NADA 30434 • NADA 12559 • NADA 11885 • NADA 130-660 • NADA 110-349 • NADA 110-350 • ANADA 200-324 • NADA 110-046 • NADA 123-815 • NADA 30136 • ANADA 200-565 • NADA 42633
Explore
Related conditions:
Congestive heart failure
Dystocia
Lameness (undifferentiated)
Metritis
Otitis Externa (Ear Infection)
Linked using:
Fda_Label (0.95),
Fda_Label (0.95),
Fda_Label (0.95)
Diagnosis Codes
ICD10_CM: H60.90
Otitis externa, unspecified ear
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
Owner-facing counseling points
- Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy; and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infections. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food. (Contraindication, High)
Top reaction signals
Tiredness (lethargy) (1)
Loss of appetite (1)
Localised pain NOS (1)
Leucocytosis NOS (1)
Lameness (1)
Lack of efficacy - NOS (1)
Ketosis (1)
Increased band neutrophilia (1)
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
Identifiers
ANADA: 200108
ANADA: 200312
ANADA: 200317
ANADA: 200324
ANADA: 200456
ANADA: 200565
NADA: 104606
NADA: 108687
NADA: 110046
NADA: 110349
NADA: 110350
NADA: 111369
NADA: 11885
NADA: 11901
NADA: 123815
NADA: 12559
NADA: 128089
NADA: 130660
NADA: 141598
NADA: 30136
NADA: 30434
NADA: 30435
NADA: 42633
NADA: 92835
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 0010-5587-01 | 0010 | - | |
| 0010-5587-02 | 0010 | - | |
| 0010-5587-03 | 0010 | - | |
| 0010-5587-04 | 0010 | - | |
| 13985-043-29 | 13985 | - | |
| 13985-533-03 | 13985 | - | |
| 13985-533-25 | 13985 | - | |
| 46066-223-04 | 46066 | - | |
| 46066-223-80 | 46066 | - | |
| 50989-437-12 | 50989 | - | |
| 57319-519-05 | 57319 | - | |
| 60270-337-10 | 60270 | - | |
| 61133-0892-9 | 61133 | - | |
| 61133-0899-9 | 61133 | - | |
| 73309-154-01 | 73309 | - | |
| 73309-154-02 | 73309 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
FOI Summary oN 141-598 Approved April 10 2025_ceg_ef.pdf
• FOI summary • Official
• June 3, 2025
FDA FOI summary for application 141598
-
ucm061771.pdf
• FOI summary • Official
• April 1, 2024
FDA FOI summary for application 200317
-
UCM492475.pdf
• FOI summary • Official
• Dec. 26, 2023
FDA FOI summary for application 200456
-
ucm061765.pdf
• FOI summary • Official
• Oct. 2, 2018
FDA FOI summary for application 200312
-
A200108_Org_4_13_1995.pdf
• FOI summary • Official
• May 16, 2017
FDA FOI summary for application 200108
-
UCM457231.pdf
• FOI summary • Official
• June 1, 2016
FDA FOI summary for application 200565
-
ucm061789.pdf
• FOI summary • Official
• June 1, 2016
FDA FOI summary for application 200324
Data Sources & Change Log
Every non-trivial field is expected to include provenance and update timestamps.
Official 10
Clinical 0
Manufacturer 0
Marketing 0
Current Field Facts
- contraindications: Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition … (Official, 2026-02-12)
- side_effects: Top reported reactions (openFDA): Vomiting, Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea, Anaphylaxis, Death, Facial swel… (Official, 2026-02-12)
- usage: In treatment of dogs as an anti-inflammatory agent. In treatment of cats as an anti-inflammatory agent. The drug is indicated for the treatment of primary bovi… (Official, 2026-02-12)
Recent Revisions
- side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
FDA Products & Applications (Animal Drugs @ FDA)
Official sponsor/proprietary-name/application-status records linked by active ingredient.
| Product | Sponsor | Application | Status | Published |
|---|---|---|---|---|
|
Otiserene®
RX
Dexamethasone Marbofloxacin Terbinafine
Otic Suspension
• Otic
|
Dechra, Ltd. | NADA 141-598 | Approved | Jun 3, 2025 |
|
Dexium-SP™
RX
Dexamethasone Sodium Phosphate
Injectable Solution
• Intravenous
|
Bimeda Animal Health Limited | ANADA 200-317 | Approved | Apr 1, 2024 |
|
Dexamethasone Solution
RX
Dexamethasone
Injectable Solution
• Intravenous, Intramuscular
|
Med-Pharmex, Inc. | ANADA 200-456 | W | Dec 26, 2023 |
|
Voren® Suspension
RX
Dexamethasone-21-isonicotinate
Liquid (Suspension)
• Intramuscular
|
Boehringer lngelheim Animal Health USA Inc. | NADA 93600 | W | May 3, 2023 |
|
Zonometh Solution
RX
Dexamethasone
Liquid (Solution)
• Intravenous, Intramuscular
|
Huvepharma EOOD | NADA 128-089 | Approved | Aug 7, 2019 |
|
Dexameth-A-Vet
RX
Dexamethasone
Liquid (Solution)
• Intravenous
|
Bimeda Animal Health Limited | NADA 99607 | Approved | Oct 2, 2018 |
|
Dexameth-A-Vet Injection
RX
Dexamethasone
Liquid (Solution)
• Intravenous
|
Bimeda Animal Health Limited | NADA 99606 | Approved | Oct 2, 2018 |
|
Dex-A-Vet Injection
RX
Dexamethasone Sodium Phosphate
Liquid (Solution)
• Intravenous
|
Bimeda Animal Health Limited | NADA 99604 | Approved | Oct 2, 2018 |
|
Dex-A-Vet Injection
RX
Dexamethasone Sodium Phosphate
Liquid (Solution)
• Intravenous
|
Bimeda Animal Health Limited | NADA 99605 | Approved | Oct 2, 2018 |
|
Dexium®
RX
Dexamethasone
Liquid (Solution)
• Intramuscular, Intravenous
|
Bimeda Animal Health Limited | ANADA 200-312 | Approved | Oct 2, 2018 |
|
Dexium™ Tablets
RX
Dexamethasone
Tablet
• Oral
|
Bimeda Animal Health Limited | NADA 95218 | Approved | Oct 2, 2018 |
|
Dexamethasone Injection
RX
Dexamethasone Sodium Phosphate
Liquid (Solution)
• Intravenous
|
Watson Laboratories, Inc. | NADA 104-606 | W | Jul 25, 2018 |
|
Dexamethasone Solution
RX
Dexamethasone
Liquid (Solution)
• Intravenous, Intramuscular
|
Huvepharma EOOD | ANADA 200-108 | Approved | May 16, 2017 |
|
Dexamethasone Sterile Solution
RX
Dexamethasone
Liquid (Solution)
• Intravenous, Intramuscular
|
Kinetic Technologies, LLC | NADA 111-369 | Approved | Nov 3, 2016 |
|
Pet Derm® III Tablets
RX
Dexamethasone
Tablet (Chewable)
• Oral
|
Kinetic Technologies, LLC | NADA 108-687 | Approved | Nov 3, 2016 |
|
Azium® Aqueous Suspension Veterinary
RX
Dexamethasone
Liquid (Solution)
• Intramuscular, Intravenous
|
Intervet, Inc. | NADA 11901 | Approved | Jun 1, 2016 |
|
Azium® Boluses 10 mg
RX
Dexamethasone
Bolus
• Oral
|
Intervet, Inc. | NADA 30435 | Approved | Jun 1, 2016 |
|
Azium® Oral Solution 2 mg
RX
Dexamethasone
Liquid
• Oral
|
Intervet, Inc. | NADA 92835 | Approved | Jun 1, 2016 |
|
Azium® Powder
RX
Dexamethasone
Powder
• Oral
|
Intervet, Inc. | NADA 30434 | Approved | Jun 1, 2016 |
|
Azium® Solution
RX
Dexamethasone
Liquid (Solution)
• Intramuscular, Intravenous
|
Intervet, Inc. | NADA 12559 | Approved | Jun 1, 2016 |
|
Azium® Tablets 0.25 mg
RX
Dexamethasone
Tablet
• Oral
|
Intervet, Inc. | NADA 11885 | Approved | Jun 1, 2016 |
|
Dexachel
RX
Dexamethasone
Liquid (Solution)
• Intravenous
|
Zoetis Inc. | NADA 130-660 | Approved | Jun 1, 2016 |
|
Dexamethasone Injection
RX
Dexamethasone Sodium Phosphate
|
Watson Laboratories, Inc. | NADA 110-349 | W | Jun 1, 2016 |
|
Dexamethasone Injection
RX
Dexamethasone
|
Watson Laboratories, Inc. | NADA 110-350 | W | Jun 1, 2016 |
|
Dexamethasone Injection
RX
Dexamethasone
Liquid (Solution)
• Intravenous, Intramuscular
|
Sparhawk Laboratories, Inc. | ANADA 200-324 | Approved | Jun 1, 2016 |
|
Dexamethasone Sodium Phosphate Inj.
RX
Dexamethasone Sodium Phosphate
|
Akorn, Inc. | NADA 110-046 | W | Jun 1, 2016 |
|
Dexamethasone Sodium Phosphate Inj.
RX
Dexamethasone Sodium Phosphate
Liquid (Solution)
• Intravenous
|
Cronus Pharma Specialities India Private Ltd. | NADA 123-815 | Approved | Jun 1, 2016 |
|
Naquasone® Bolus
RX
Dexamethasone Trichlormethiazide
Bolus
• Oral
|
Intervet, Inc. | NADA 30136 | Approved | Jun 1, 2016 |
|
Thiabendazole, Dexamethasone, Neomycin Sulfate Solution
RX
Dexamethasone Neomycin Sulfate Thiabendazole
Solution
• Topical
|
Dechra Veterinary Products LLC | ANADA 200-565 | Approved | Jun 1, 2016 |
|
Tresaderm Dermatologic Solution
RX
Dexamethasone Neomycin Sulfate Thiabendazole
Liquid (Solution)
• Topical
|
Boehringer lngelheim Animal Health USA, Inc. | NADA 42633 | Approved | Jun 1, 2016 |
Data source: FDA Animal Drugs @ FDA (public search export).
What It's For (FDA Label Highlights)
Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.
Composition / specifications
15.1 mg marbofloxacin, 22.7 mg terbinafine, 2.01 mg dexamethasone per tube
Dogs
Indication
For the treatment of otitis externa associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius) in dogs.
Dosage
Administer one dose (1 tube) per affected ear once.
Limitations
FDA page: Open in Animal Drugs @ FDA
Species: No Use Class Stated Or Implied
Composition / specifications
Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams dexamethasone).
Horses
Indication
The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses.
Dosage
The drug is administered intravenously at a dosage of 2.5 to 5.0 milligrams. If permanent corticosteroid effect is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: No Use Class Stated Or Implied • No Use Class Stated Or Implied
Composition / specifications
Each milliliter of solution contains 2 milligrams dexamethasone.
Cattle
Indication
For the treatment of primary bovine ketosis and as an anti-inflammatory agent.
Dosage
5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
For use as an anti-inflammatory agent.
Dosage
2.5 to 5 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, Restricted During Pregnancy • Horse, Not For Meat Production • Cat, Restricted During Pregnancy
Composition / specifications
Each milliliter of sterile suspension contains 1 milligram of dexamethasone-21-isonicotinate.
Cats
Indication
The drug is used in the treatment of various inflammatory conditions associated with the musculoskeletal system in cats.
Dosage
It is recommended for intramuscular administration as 0.125 to 0.5 milligrams. Dosage may be repeated.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition following by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
The drug is used in the treatment of various inflammatory conditions associated with the musculoskeletal system in dogs.
Dosage
It is recommended for intramuscular administration as -0.25 to 1 milligrams. Dosage may be repeated.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition following by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
The drug is used in the treatment of various inflammatory conditions associated with the musculoskeletal system in horses.
Dosage
It is recommended for intramuscular administration as 5 to 20 milligrams. Dosage may be repeated.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition following by dystocia, fetal death, retained placenta, and metritis. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production • Cat, No Use Class Stated Or Implied
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 2.0 milligrams of dexamethasone
Dogs
Indication
The drug is used as an anti-inflammatory agent.
Dosage
0.25 to 1 milligrams administered intravenously or intramuscularly.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
The drug is used as an anti-inflammatory agent.
Dosage
0.125 to 0.5 milligrams administered intravenously or intramuscularly.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
The drug is used as an anti-inflammatory agent.
Dosage
2.5 to 5 milligrams administered intravenously or intramuscularly.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Horse, Not For Meat Production
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains either 2.0 milligrams of dexamethasone or 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams of dexamethasone).
Horses
Indication
The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent.
Dosage
The drug is administered intravenously at a dosage of 2.5 to 5.0 milligrams. If permanent corticosteroid effect is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.
Limitations
Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains either 2.0 milligrams of dexamethasone or 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams dexamethasone).
Dogs
Indication
The drug is used in dogs for the treatment of inflammatory conditions, as supportive therapy in canine posterior paresis, as supportive therapy before or after surgery to enhance recovery of poor surgical risks, and as supportive therapy in nonspecific dermatosis.
Dosage
The drug is administered intravenously at 0.25 to 1 milligram initially. The dose may be repeated for 3 to 5 days or until a response is noted. If continued treatment is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Horse, Not For Meat Production
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams of dexamethasone).
Horses
Indication
The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses.
Dosage
The drug is administered intravenously at a dosage of 2.5 to 5.0 milligrams. If permanent corticosteroid effect is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.
Limitations
Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams dexamethasone).
Dogs
Indication
The drug is used in dogs for the treatment of inflammatory conditions, as supportive therapy in canine posterior paresis, as supportive therapy before or after surgery to enhance recovery of poor surgical risks, and as supportive therapy in nonspecific dermatosis.
Dosage
The drug is administered intravenously at 0.25 to 1 milligram initially. The dose may be repeated for 3 to 5 days or until a response is noted. If continued treatment is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Horse, No Use Class Stated Or Implied • No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter contains 2 milligrams of dexamethasone.
Horses
Indication
The drug is indicated as an anti-inflammatory agent in horses.
Dosage
2.5 to 5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food.
Cattle
Indication
The drug is indicated as an anti-inflammatory agent in cattle.
Dosage
5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
The drug is indicated as an anti-inflammatory agent in cats.
Dosage
0.125 to 0.5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
The drug is indicated as an anti-inflammatory agent in dogs.
Dosage
0.25 to 1 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each tablet contains 0.25 milligram of dexamethasone.
Cats
Indication
Dexamethasone is indicated for use as an anti-inflammatory agent
Dosage
Administer orally at 0.125 to 0.5 mg. per day up to 7 days
Limitations
Do not use in viral infections.
Except for emergency therapy, do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome and peptic ulcers. Existence of congestive heart failure, diabetes and osteoporosis are relative contraindications.
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition if used during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis.
Additionally, corticosteroids administered to dogs, rabbits and rodents during pregnancy have resulted in cleft palate in offspring. Corticosteroids administered to dogs during pregnancy have also resulted in other congenital anomalies including deformed forelegs, phocomelia and anasarca.
Dogs
Indication
Dexamethasone is indicated for use as an anti-inflammatory agent
Dosage
Administer orally at 0.25 to 1.25 mg. per day up to 7 days
Limitations
Do not use in viral infections.
Except for emergency therapy, do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome and peptic ulcers. Existence of congestive heart failure, diabetes and osteoporosis are relative contraindications.
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition if used during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis.
Additionally, corticosteroids administered to dogs, rabbits and rodents during pregnancy have resulted in cleft palate in offspring. Corticosteroids administered to dogs during pregnancy have also resulted in other congenital anomalies including deformed forelegs, phocomelia and anasarca.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams dexamethasone).
Dogs
Indication
The drug is used in dogs for the treatment of inflammatory conditions, as supportive therapy in canine posterior paresis as supportive therapy before or after surgery to enhance recovery of poor surgical risks, and as supportive therapy in nonspecific dermatosis.
Dosage
The drug is administered intravenously at 0.25 to 1 milligram initially. The dose may be repeated for 3 to 5 days or until a response is noted. If continued treatment is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
The drug is used as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses.
Dosage
The drug is administered intravenously at a dosage of 2.5 to 5.0 milligrams. If permanent corticosteroid effect is required, oral therapy may be substituted. When therapy is withdrawn after prolonged use, the daily dose should be reduced gradually over several days.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production • No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 2 milligrams of dexamethasone.
Cats
Indication
The drug is indicated as an anti-inflammatory agent.
Dosage
0.125 to 0.5 milligrams depending on the severity of the condition. The drug is administered intravenously or intramuscularly and dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
The drug is indicated as an anti-inflammatory agent.
Dosage
2.5 to 5 milligrams depending on the severity of the condition. The drug is administered intravenously or intramuscularly and dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
The drug is indicated as an anti-inflammatory agent.
Dosage
0.25 to 1 milligrams depending on the severity of the condition. The drug is administered intravenously or intramuscularly and dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cattle
Indication
The drug is indicated as an anti-inflammatory agent.
Dosage
5 to 20 milligrams depending on the severity of the condition. The drug is administered intravenously or intramuscularly and dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production • Cat, No Use Class Stated Or Implied
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 2.0 milligrams of dexamethasone
Dogs
Indication
The drug is used as an anti-inflammatory agent.
Dosage
0.25 to 1 milligram administered intravenously or intramuscularly.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
The drug is used as an anti-inflammatory agent.
Dosage
0.125 to 0.5 milligrams administered intravenously or intramuscularly.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
The drug is used as an anti-inflammatory agent.
Dosage
2.5 to 5 milligrams administered intravenously or intramuscularly.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, Restricted During Pregnancy
Composition / specifications
Each half-scored tablet contains 0.25 milligrams of dexamethasone.
Dogs
Indication
Supportive therapy in nonspecific dermatosis and inflammatory conditions.
Dosage
0.25 to 1.25 milligrams per day. Administer by free-choice feeding or crumble over food. Administer 0.25 to 1.25 milligrams daily in single or two divided doses until response is noted or 7 days have elapsed. When response is attained, dosage should be gradually reduced by 0.125 milligram per day until maintenance level is achieved.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy, and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infection. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production • No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 2 milligrams of dexamethasone.
Cattle
Indication
The drug is indicated for the treatment of primary bovine ketosis.
Dosage
5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly; the dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
The drug is indicated as an anti-inflammatory agent in horses.
Dosage
2.5 to 5 milligrams administered intravenously or intramuscularly; the dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food.
Cats
Indication
The drug is indicated as an anti-inflammatory agent in cats.
Dosage
0.125 to 0.5 milligrams administered intravenously or intramuscularly; the dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
The drug is indicated as an anti-inflammatory agent in dogs.
Dosage
0.25 to 1 milligrams administered intravenously or intramuscularly; the dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Horse, No Use Class Stated Or Implied • No Use Class Stated Or Implied
Composition / specifications
Each bolus is half-scored and contains 10 milligrams of dexamethasone.
Cattle
Indication
Dexamethasone bolus is indicated in cases where cattle require additional steroid therapy following its parenteral administration. The drug may be used as supportive therapy for management of inflammatory conditions such as acute arthritic lameness; and for various stress conditions where corticosteroids are required while the animal is being treated for a specific condition.
Dosage
Administered orally, 5 to 10 milligrams for the first day, then 5 milligrams per day as required.
Limitations
Do not use in viral infections during the viremic stage. With bacterial infections, appropriate antibacterial therapy should be used. Do not use in animals with chronic nephritis and hypercorticalism (cushingoid syndrome) except for emergency therapy. Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.
Horses
Indication
Dexamethasone bolus is indicated in cases where horses require additional steroid therapy following its parenteral administration. The drug may be used as supportive therapy for management of inflammatory conditions such as acute arthritic lameness es; and for various stress conditions where corticosteroids are required while the animal is being treated for a specific condition.
Dosage
Administered orally, 5 to 10 milligrams for the first day, then 5 milligrams per day as required.
Limitations
Do not use in viral infections during the viremic stage. With bacterial infections, appropriate antibacterial therapy should be used. Do not use in animals with chronic nephritis and hypercorticalism (cushingoid syndrome) except for emergency therapy. Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Horse, No Use Class Stated Or Implied • No Use Class Stated Or Implied
Composition / specifications
Dexamethasone powder is packaged in packets containing 10 milligrams of dexamethasone.
Cattle
Indication
Dexamethasone powder is indicated in cases where cattle require additional steroid therapy following its parenteral administration. The drug is used as supportive therapy for management or inflammatory conditions such as acute arthritic lameness; and for various stress conditions where corticosteroids are required while the animal is being treated for a specific condition.
Dosage
The drug is administered at a dosage level of 5 to 10 milligrams per animal the first day then 5 milligrams per day as required by drench or by sprinkling on a small amount of feed.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.
Horses
Indication
Dexamethasone powder is indicated in cases where horses require additional steroid therapy following its parenteral administration. The drug is used as supportive therapy for management or inflammatory conditions such as acute arthritic lameness; and for various stress conditions where corticosteroids are required while the animal is being treated for a specific condition.
Dosage
The drug is administered at a dosage level of 5 to 10 milligrams per animal the first day then 5 milligrams per day as required by drench or by sprinkling on a small amount of feed.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production • No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 2 milligrams of dexamethasone.
Dogs
Indication
The drug is indicated as an anti-inflammatory agent in dogs.
Dosage
0.25 to 1 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
The drug is indicated as an anti-inflammatory agent in cats.
Dosage
0.125 to 0.5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cattle
Indication
The drug is indicated as an anti-inflammatory agent in cattle.
Dosage
5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
The drug is indicated as an anti-inflammatory agent in horses.
Dosage
2.5 to 5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each tablet contains 0.25 milligram of dexamethasone.
Dogs
Indication
In treatment of dogs as an anti-inflammatory agent.
Dosage
Administer orally at 0.25 to 1.25 milligrams per day for up to 7 days.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy; and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infections. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
In treatment of cats as an anti-inflammatory agent.
Dosage
Administer orally at 0.125 to 0.5 milligram per day for up to 7 days.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy; and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infections. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production • Cat, No Use Class Stated Or Implied
Composition / specifications
The drug is a sterile aqueous solution. Each milliliter contains 2.0 milligrams of dexamethasone
Dogs
Indication
The drug is used as an anti-inflammatory agent.
Dosage
0.25 to 1 milligrams administered intravenously.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
The drug is used as an anti-inflammatory agent.
Dosage
0.125 to 0.5 milligrams administered intravenously.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
The drug is used as an anti-inflammatory agent.
Dosage
2.5 to 5 milligrams administered intravenously.
Limitations
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Horse, No Use Class Stated Or Implied • No Use Class Stated Or Implied
Composition / specifications
Each milliliter contains 2 milligrams of dexamethasone.
Cattle
Indication
For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle.
Dosage
5 to 20 milligrams depending on the severity of the condition administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
The drug is indicated as an anti-inflammatory agent in horses.
Dosage
2.5 to 5 milligrams administered intravenously or intramuscularly. Dosage may be repeated if necessary.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Horse, Not For Meat Production
Composition / specifications
Specifications: The drug is a sterile aqueous solution. Each milliliter contains 4.0 milligrams of dexamethasone sodium phosphate (equivalent to 3.0 milligrams of dexamethasone).
Dogs
Indication
The drug is given for glucocorticoid and anti-inflammatory agent.
Dosage
0.25 to 1 milligram initially, administered intravenously. May be repeated for 3 to 5 days or until response is noted.
Limitations
If permanent glucocorticoid effect is required, oral therapy may be substituted. When therapy is to be withdraw after prolonged use, the daily dose should be reduced gradually over several days. Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of glucocorticoids may mask signs of infection. Except when used for emergency therapy, the product is contraindicated in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Horses
Indication
The drug is given for glucocorticoid and anti-inflammatory agent.
Dosage
2.5 to 5 milligrams administered intravenously.
Limitations
If permanent glucocorticoid effect is required, oral therapy may be substituted. When therapy is to be withdraw after prolonged use, the daily dose should be reduced gradually over several days. Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of glucocorticoids may mask signs of infection. Except when used for emergency therapy, the product is contraindicated in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of solution contains 40 milligrams (mg) thiabendazole, 3.2 mg neomycin (from neomycin sulfate), and 1 mg dexamethasone.
Label highlights
Indication
As an aid in the treatment of bacterial, mycotic, and inflammatory dermatoses and otitis externa
Dosage
In treating dermatoses affecting areas other than the ear, the surface of the lesions should be well moistened (2 to 4 drops per square inch) twice daily. In treating otitis externa, instill 5 to 15 drops in the ear twice daily. Treat for up to 7 days
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian
FDA page: Open in Animal Drugs @ FDA
Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each cubic centimeter of neomycin sulfate-thiabendazole-dexamethasone solution contains: 40 milligrams of thiabendazole, 3.2 milligrams of neomycin (from neomycin sulfate), and 1 milligram of dexamethasone.
Cats
Indication
The drug is recommended for use as an aid in the treatment of bacterial, mycotic, and inflammatory dermatoses and otitis externa in cats.
Dosage
In treating dermatoses affecting areas other than the ear, the surface of the lesions should be well moistened (two to four drops per square inch) twice daily. In treating otitis externa, five to 15 drops of the drug should be instilled in the ear twice daily. The is limited to 7 days maximum duration of administration.
Limitations
For use only by or on order of a licensed veterinarian.
Dogs
Indication
The drug is recommended for use as an aid in the treatment of bacterial, mycotic, and inflammatory dermatoses and otitis externa in dogs.
Dosage
In treating dermatoses affecting areas other than the ear, the surface of the lesions should be well moistened (two to four drops per square inch) twice daily. In treating otitis externa, five to 15 drops of the drug should be instilled in the ear twice daily. The is limited to 7 days maximum duration of administration.
Limitations
For use only by or on order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Official Documents (FDA)
Direct links to FDA-hosted PDFs and SPL packages (when available).
Documents
-
Summary
For the treatment of otitis externa associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius) in dogs.
SPL Packages
- Otiserene® (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
FOI ucm061771.pdf
Summary
For use as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses.
SPL Packages
- Dexium-SP™ (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
FOI UCM492475.pdf
Summary
For the treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses.
SPL Packages
- Dexamethasone Solution (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Voren® Suspension (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Zonometh Solution (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Dexameth-A-Vet (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Dexameth-A-Vet Injection (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Dex-A-Vet Injection (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Dex-A-Vet Injection (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
FOI ucm061765.pdf
Summary
For treatment of primary bovine ketosis and as an anti-inflammatory agent in the canine, feline, bovine and equine.
SPL Packages
- Dexium® (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Dexium™ Tablets (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Dexamethasone Injection (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
Summary
Treatment of primary bovine ketosis and as an anti-inflammatory agent in dogs, cats, cattle, and horses.
SPL Packages
- Dexamethasone Solution (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Pet Derm® III Tablets (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Azium® Boluses 10 mg (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Azium® Powder (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Azium® Solution (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Azium® Tablets 0.25 mg (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Dexachel (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Dexamethasone Injection (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Dexamethasone Injection (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
FOI ucm061789.pdf
Summary
Treatment of primary bovine ketosis and as an anti-inflammatory agent in cattle and horses.
SPL Packages
- Dexamethasone Injection (ZIP)
FDA page: Open in Animal Drugs @ FDA
SPL Packages
FDA page: Open in Animal Drugs @ FDA
SPL Packages
FDA page: Open in Animal Drugs @ FDA
SPL Packages
- Naquasone® Bolus (ZIP)
FDA page: Open in Animal Drugs @ FDA
Documents
-
FOI UCM457231.pdf
Summary
As an aid in the treatment of certain bacterial, mycotic, and inflammatory dermatoses and otitis externa in dogs and cats.
SPL Packages
FDA page: Open in Animal Drugs @ FDA
SPL Packages
FDA page: Open in Animal Drugs @ FDA
Usage
In treatment of dogs as an anti-inflammatory agent. In treatment of cats as an anti-inflammatory agent. The drug is indicated for the treatment of primary bovine ketosis.
Source: FDA Animal Drugs @ FDA • Reference
Contraindications
Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition when administered during the last trimester of pregnancy; and they may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Do not use in viral infections. Anti-inflammatory action of corticosteroids may mask signs of infections. Do not use in animals with tuberculosis, chronic nephritis, cushingoid syndrome, or peptic ulcers, except for emergency therapy. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food.
Top Reported Reactions (openFDA)
De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).
Digestive
Loss of appetite (1)
• Dog
Diarrhea (1)
• Dog
Decreased appetite (1)
• Cat
Showing top 5 for Digestive.
Neurologic
Unsteady walking (1)
• Cat
Tiredness (1)
• Dog
Showing top 5 for Neurologic.
Effectiveness
Lack of efficacy - NOS (1)
• Dog
Showing top 5 for Effectiveness.
Other
Localised pain NOS (1)
• Dog
Leucocytosis NOS (1)
• Dog
Lameness (1)
• Dog
Ketosis (1)
• Cat
Increased drinking (1)
• Cat
Show more (21)
Increased band neutrophilia (1)
• Dog
Hypothermia (1)
• Dog
Hypokalaemia (1)
• Dog
Hypernatremia (1)
• Dog
Hyperglycaemia (1)
• Cat
Hyperchloraemia (1)
• Dog
Hot spot (1)
• Dog
Gastroenteritis (1)
• Dog
Fever (1)
• Dog
Elevated renal parameters (1)
• Cat
Elevated blood urea nitrogen (1)
• Dog
Elevated alanine aminotransferase (1)
• Dog
Diabetes mellitus (1)
• Cat
Dermatitis (1)
• Dog
Dehydration (1)
• Dog
Decreased blood urea nitrogen (BUN) or creatinine (1)
• Dog
Death (1)
• Dog
Constricted pupils (1)
• Dog
Anal sac disorder (1)
• Dog
Abnormal radiograph finding (1)
• Cat
Abnormal cytology (1)
• Dog
Showing top 5 for Other.
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Dog, Chihuahua, Female, 12.2 year, 3.901 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Vomiting, Underdose, Hypothermia, Unsteady walking (ataxia), Dehydration… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-054506
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Age: 12.20 Year
- Weight: 3.901 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Unassigned
Reactions Reported:
Vomiting
Underdose
Hypothermia
Unsteady walking (ataxia)
Dehydration
Tiredness (lethargy)
Loss of appetite
Leucocytosis NOS
Neutrophilia
Increased band neutrophilia
Monocytosis
Thrombocytosis
Elevated blood urea nitrogen
Decreased blood urea nitrogen (BUN) or creatinine
Other abnormal test result NOS
Outcomes: Ongoing
Cat, Domestic Shorthair, Male, 3 year, 5.65 kilogram • Drug: MSK, Topical, Dose: 6 drops per animal, Frequency: 12 per hour • Reactions: Tiredness (lethargy), Vomiting, Otitis media, Tympanic alteration, Abnormal radiograph finding… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-056132
- Serious AE: No
- Treated For AE: Yes
- Sex: Male
- Age: 3.00 Year
- Weight: 5.650 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Topical
- Dose: 6 drops per animal
- Frequency: 12 per hour
Reactions Reported:
Tiredness (lethargy)
Vomiting
Otitis media
Tympanic alteration
Abnormal radiograph finding
Not eating
Abnormal cytology
Outcomes: Ongoing
Dog, Terrier (unspecified), Female, 15 year, 4.264 kilogram • Drug: MSK, Liquid, Unknown • Reactions: Seizure NOS, Not defecating, Fever, Tiredness (lethargy), Localised pain NOS… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-053704
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Age: 15.00 Year
- Weight: 4.264 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Liquid
Reactions Reported:
Seizure NOS
Not defecating
Fever
Tiredness (lethargy)
Localised pain NOS
Not eating
Anal sac disorder
Shaking
Medication error NOS
Outcomes: Ongoing
Cat, Cat (unknown), Unknown • Drug: MSK, Unknown • Reactions: Increased drinking, Reluctant to move, Tiredness (lethargy) • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2025-US-054681
- Serious AE: No
- Treated For AE: No
- Sex: Unknown
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Reactions Reported:
Increased drinking
Reluctant to move
Tiredness (lethargy)
Outcomes: Recovered/Normal
Cat, Domestic Shorthair, Male, 16 year • Drug: MSK, Oral • Reactions: Neuropathy NOS, Tiredness (lethargy), Hyperglycaemia, Diabetes mellitus, Ketosis… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-051645
- Serious AE: Yes
- Treated For AE: No
- Sex: Male
- Age: 16.00 Year
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
Reactions Reported:
Neuropathy NOS
Tiredness (lethargy)
Hyperglycaemia
Diabetes mellitus
Ketosis
Sleepiness - neurological disorder
Elevated renal parameters
Outcomes: Ongoing
Cat, American Shorthair, Female, 6 year, 4.781 kilogram • Drug: MSK, Auricular (Otic), Dose: 6 drops per animal, Frequency: 12 per hour • Reactions: Unsteady walking (ataxia), Loss of appetite, Nystagmus • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-054206
- Serious AE: No
- Treated For AE: Yes
- Sex: Female
- Age: 6.00 Year
- Weight: 4.781 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Auricular (Otic)
- Dose: 6 drops per animal
- Frequency: 12 per hour
Reactions Reported:
Unsteady walking (ataxia)
Loss of appetite
Nystagmus
Outcomes: Outcome Unknown
Dog, Crossbred Canine/dog, Male, 2.5 year, 19.142 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Vomiting, Diarrhea, Stress leukogram, Elevated alanine aminotransferase, Hyperglycaemia… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-052590
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 2.50 Year
- Weight: 19.142 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Unassigned
Reactions Reported:
Vomiting
Diarrhea
Stress leukogram
Elevated alanine aminotransferase
Hyperglycaemia
Gastroenteritis
Lameness
Neoplasia NOS
Pulmonary metastases
Abnormal radiograph finding
Outcomes: Ongoing
Dog, Retriever - Labrador, Female, 9 year, 28.35 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Lack of efficacy - NOS, Abnormal cytology • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-053366
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Age: 9.00 Year
- Weight: 28.350 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Unassigned
Reactions Reported:
Lack of efficacy - NOS
Abnormal cytology
Outcomes: Ongoing
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.
Storage & Handling
No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
No community reviews yet. Be the first to share your experience.
This medication has not been reviewed by a veterinarian yet.
Medical Disclaimer: The medication details provided on Roxee are for informational purposes only and are not a substitute for professional veterinary advice. Always consult your veterinarian about your pet's specific needs.